High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Velcheti, Vamsidhar ^a   Schalper, Kurt ^a   Yao, Xiaopan ^b   Cheng, Huan ^a   Kocoglu, Mehmet ^a   Dhodapkar, Kavita ^a   Deng, Yanhong ^b   Gettinger, Scott ^a   Rimm, David L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale Center for Applied Biostatistics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR SOX2;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; TISSUE MICROARRAY;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; COHORT STUDIES; CONNECTICUT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GREECE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REPRODUCIBILITY OF RESULTS; SOXB1 TRANSCRIPTION FACTORS; SURVIVAL ANALYSIS; TISSUE ARRAY ANALYSIS; TREATMENT OUTCOME;

EID: 84876432621     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061427     Document Type: Article

References (25)

1. Lefebvre V, Dumitriu B, Penzo-Mendez A, Han Y, Pallavi B, (2007) Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int J Biochem Cell Biol 39: 2195-2214.
2. Gontan C, de Munck A, Vermeij M, Grosveld F, Tibboel D, et al. (2008) Sox2 is important for two crucial processes in lung development: branching morphogenesis and epithelial cell differentiation. Dev Biol 317: 296-309.
3. Graham V, Khudyakov J, Ellis P, Pevny L, (2003) SOX2 functions to maintain neural progenitor identity. Neuron 39: 749-765.
4. Yuan P, Kadara H, Behrens C, Tang X, Woods D, et al. (2010) Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung. PLoS One 5: e9112.
5. Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, et al. (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366: 2455-2465.
6. Freier K, Knoepfle K, Flechtenmacher C, Pungs S, Devens F, et al. (2010) Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma. Genes Chromosomes Cancer 49: 9-16.
7. Long KB, Hornick JL, (2009) SOX2 is highly expressed in squamous cell carcinomas of the gastrointestinal tract. Hum Pathol 40: 1768-1773.
8. Maier S, Wilbertz T, Braun M, Scheble V, Reischl M, et al. (2011) SOX2 amplification is a common event in squamous cell carcinomas of different organ sites. Hum Pathol 42: 1078-1088.
9. Lengerke C, Fehm T, Kurth R, Neubauer H, Scheble V, et al. (2011) Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer 11: 42.
10. Zhang X, Yu H, Yang Y, Zhu R, Bai J, et al. (2010) SOX2 in gastric carcinoma, but not Hath1, is related to patients' clinicopathological features and prognosis. J Gastrointest Surg 14: 1220-1226.
11. Neumann J, Bahr F, Horst D, Kriegl L, Engel J, et al. (2011) SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. BMC Cancer 11: 518.
12. Wang X, Liang Y, Chen Q, Xu HM, Ge N, et al. (2012) Prognostic significance of SOX2 expression in nasopharyngeal carcinoma. Cancer Invest 30: 79-85.
13. Saigusa S, Mohri Y, Ohi M, Toiyama Y, Ishino Y, et al. (2011) Podoplanin and SOX2 expression in esophageal squamous cell carcinoma after neoadjuvant chemo-radiotherapy. Oncol Rep 26: 1069-1074.
14. Matsuoka J, Yashiro M, Sakurai K, Kubo N, Tanaka H, et al. (2012) Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res 174: 130-135.
15. Ge N, Lin HX, Xiao XS, Guo L, Xu HM, et al. (2010) Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma. J Transl Med 8: 94.
16. Huang P, Qiu J, Li B, Hong J, Lu C, et al. (2011) Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy. Clin Biochem 44: 582-589.
17. Wilbertz T, Wagner P, Petersen K, Stiedl AC, Scheble VJ, et al. (2011) SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Mod Pathol 24: 944-953.
18. Sholl LM, Barletta JA, Yeap BY, Chirieac LR, Hornick JL, (2010) Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma. Am J Surg Pathol 34: 1193-1198.
19. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, et al. (2009) SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 41: 1238-1242.
20. Hussenet T, Dali S, Exinger J, Monga B, Jost B, et al. (2010) SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas. PLoS One 5: e8960.
21. McCabe A, Dolled-Filhart M, Camp RL, Rimm DL, (2005) Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis. J Natl Cancer Inst 97: 1808-1815.
22. Camp RL, Chung GG, Rimm DL, (2002) Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 8: 1323-1327.
23. Camp RL, Dolled-Filhart M, Rimm DL, (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10: 7252-7259.
24. Kao J, Salari K, Bocanegra M, Choi Y-L, Girard L, et al. (2009) Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery. PLoS One 4: e6146.
25. Tolles J, Bai Y, Baquero M, Harris LN, Rimm DL, et al. (2011) Optimal tumor sampling for immunostaining of biomarkers in breast carcinoma. Breast Cancer Res 13: R51.